DepoDur
From Wikipedia, the free encyclopedia
DepoDur, previously known as DepoMorphine, is a morphine sulfate extended-release liposome injection (see Depot injection), product of SkyePharma PLC. It was approved by the FDA in 2004 for use as a post-surgical pain reliever. In Europe it was approved by the Medicines and Healthcare products Regulatory Agency in 2006.
It is a one-time injection (during or shortly after surgery) that maintains a therapeutically effective level of morphine in the patient's bloodstream for 48 hours.
[edit] External links
 |
This pharmacology-related article is a stub. You can help Wikipedia by expanding it. |
